Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy

Figure 4 Rates of remission or response and steroid-free remission in the combination therapies of cytapheresis and biologics in inflammatory bowel disease patients showing insufficient response or loss of response to biologics. Box plot shows that the remission rates in the combination therapies of cytapheresis and biologics range from 32%-100% (mean: 62.72%, median: 57.85%, interquartile range: 40.175%-89.275%), and the rates of steroid-free remission in the combination therapies range from 9%-75% (mean: 43%, median: 44%, interquartile range: 16.25%-68.75%).